Register for a Premier or General Access pass to attend 135 sessions in these focus areas:
-
AI and Digital Health
-
Biomanufacturing
-
Brain Health
-
Business Development and Investment
-
Cell and Gene Therapy and Genome Editing
-
Diagnostics and Personalized Medicine
-
Emerging Opportunities in Global Markets
-
Environmental Sustainability
-
Infectious Disease and Vaccines
-
Intellectual Property and Legal Landscape
-
Next Generation Biotherapeutics
-
Oncology
-
Orphan and Rare Diseases
-
Patient Advocacy
-
Science and Regulatory Innovation
-
Translational Research
-
Value, Patient Access, and Reimbursement
-
Workforce, Health Equity, and Leadership
The 2026 Program will be announced in mid-March. Sign up to receive email updates, including session and speaker information.


